Brain galanin system genes interact with life stresses in depression-related phenotypes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 16, 2014, Pages

  Juhasz, Gabriella ^a,b,c   Hullam, Gabor ^b,d   Eszlari, Nora ^a,b   Gonda, Xenia ^a,b   Antal, Peter ^d   Anderson, Ian Muir ^c   Hökfelt, Tomas G M ^e   Deakin, J F William ^c,f   Bagdy, Gyorgy ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^e KAROLINSKA INSTITUTE   (Sweden)

^f GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Galanin receptors; Mood disorders; Network based analysis; Neurogenesis; Transmitter coexistence

Indexed keywords

GALANIN; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; GALANIN RECEPTOR 3; SEROTONIN TRANSPORTER;

ADULT; ANXIETY; ARTICLE; DEPRESSION; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; LIFE EVENT; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

GALANIN RECEPTORS; MOOD DISORDERS; NETWORK-BASED ANALYSIS; NEUROGENESIS; TRANSMITTER COEXISTENCE;

ADULT; BAYES THEOREM; BRAIN; COMPUTER SIMULATION; DEMOGRAPHY; DEPRESSION; FEMALE; GALANIN; GENE-ENVIRONMENT INTERACTION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LOGISTIC MODELS; MALE; MODELS, BIOLOGICAL; MULTILEVEL ANALYSIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GALANIN; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84899101173     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1403649111     Document Type: Article

References (108)

1. Kessler RC, et al.; National Comorbidity Survey Replication (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095-3105. (Pubitemid 37432885)
2. Wittchen HU (2012) The burden of mood disorders. Science 338(6103):15.
3. Kendler KS (2012) The dappled nature of causes of psychiatric illness: Replacing the organic-functional/hardware-software dichotomy with empirically based pluralism. Mol Psychiatry 17(4):377-388.
4. Kendler KS (2013) What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol Psychiatry 18(10):1058-1066.
5. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 157(10):1552-1562.
6. Maes M, Meltzer HY (1995) The serotonin hypothesis of major depression. Psychopharmacology: The Fourth Generation of Progress, eds Bloom FE, Kupfer DJ (Raven Press, New York), pp 933-944.
7. Schatzberg AF, Schildkraut JJ (1995) Recent studies on norepinephrine systems in mood disorders. Psychopharmacology: The Fourth Generation of Progress, eds Bloom FE, Kupfer DJ (Raven Press, New York), pp 911-920.
8. Millan MJ (2006) Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110(2):135-370.
9. Trivedi MH, et al.; STAR*D Study Team (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry 163(1):28-40. (Pubitemid 43050100)
10. Burbach JP (2010) Neuropeptides from concept to online database www.neuropeptides. nl. Eur J Pharmacol 626(1):27-48.
11. Griebel G, Holsboer F (2012) Neuropeptide receptor ligands as drugs for psychiatric diseases: The end of the beginning? Nat Rev Drug Discov 11(6):462-478.
12. Hökfelt T, Bartfai T, Bloom F (2003) Neuropeptides: Opportunities for drug discovery. Lancet Neurol 2(8):463-472. (Pubitemid 36876103)
13. Holmes A, Heilig M, Rupniak NM, Steckler T, Griebel G (2003) Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24(11):580-588. (Pubitemid 37357142)
14. Nemeroff CB, ValeWW(2005) The neurobiology of depression: Inroads to treatment and new drug discovery. J Clin Psychiatry 66(Suppl 7):5-13. (Pubitemid 41345489)
15. Steckler T (2008) Peptide receptor ligands to treat anxiety disorders. Handbook of Anxiety and Fear, eds Blanchard RJ, Blanchard DC, Griebel G, Nutt D (Elsevier, Amsterdam), pp 157-217.
16. Griebel G, Holmes A (2013) 50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov 12(9):667-687.
17. Maubach KA, Rupniak NM, Kramer MS, Hill RG (1999) Novel strategies for pharmacotherapy of depression. Curr Opin Chem Biol 3(4):481-488. (Pubitemid 29376111)
18. Sajdyk TJ, Shekhar A, Gehlert DR (2004) Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 38(4):225-234. (Pubitemid 39158861)
19. Wu G, et al. (2011) Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 15(11):1317-1331.
20. Ranga K, Krishnan R (2002) Clinical experience with substance P receptor (NK1) antagonists in depression. J Clin Psychiatry 63(Suppl 11):25-29.
21. Wrenn CC, Crawley JN (2001) Pharmacological evidence supporting a role for galanin in cognition and affect. Prog Neuropsychopharmacol Biol Psychiatry 25(1):283-299. (Pubitemid 32173796)
22. Tatemoto K, Rökaeus Å, Jörnvall H, McDonald TJ, Mutt V (1983) Galanin - A novel biologically active peptide from porcine intestine. FEBS Lett 164(1):124-128. (Pubitemid 14201839)
23. Skofitsch G, Jacobowitz DM (1985) Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 6(3):509-546. (Pubitemid 16255665)
24. Melander T, Hökfelt T, Rökaeus A (1986) Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol 248(4):475-517. (Pubitemid 16073027)
25. Kordower JH, Le HK, Mufson EJ (1992) Galanin immunoreactivity in the primate central nervous system. J Comp Neurol 319(4):479-500.
26. Le Maître E, Barde SS, Palkovits M, Diaz-Heijtz R, Hökfelt TG (2013) Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe. Proc Natl Acad Sci USA 110(6):E536-E545.
27. Gentleman SM, et al. (1989) Distribution of galanin-like immunoreactivity in the human brain. Brain Res 505(2):311-315. (Pubitemid 20013170)
28. Melander T, et al. (1986) Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 6(12):3640-3654. (Pubitemid 17208548)
29. Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48(1):113-178.
30. Khoshbouei H, Cecchi M, Morilak DA (2002) Modulatory effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuropsychopharmacology 27(1):25-34. (Pubitemid 34626740)
31. Holmes PV, Blanchard DC, Blanchard RJ, Brady LS, Crawley JN (1995) Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus. Pharmacol Biochem Behav 50(4):655-660.
32. Sweerts BW, Jarrott B, Lawrence AJ (1999) Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats. Brain Res Mol Brain Res 69(1):113-123. (Pubitemid 29238192)
33. Lang R, Gundlach AL, Kofler B (2007) The galanin peptide family: Receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther 115(2):177-207. (Pubitemid 47042915)
34. Branchek TA, Smith KE, Gerald C, Walker MW (2000) Galanin receptor subtypes. Trends Pharmacol Sci 21(3):109-117. (Pubitemid 30114326)
35. O'Donnell D, et al. (2003) Localization of galanin receptor subtypes in the rat CNS. Handbook of Chemical Neuroanatomy, Vol. 20, Peptide Receptors, Part II, eds Quirion R, Björklund A, Hökfelt T (Elsevier, Amsterdam), pp 195-244.
36. Köhler C, et al. (1989) Distribution of galanin-binding sites in the monkey and human telencephalon: Preliminary observations. Exp Brain Res 75(2):375-380. (Pubitemid 19110674)
37. Fuxe K, et al. (1998) Galanin modulates 5-hydroxytryptamine functions. Focus on galanin and galanin fragment/5-hydroxytryptamine1A receptor interactions in the brain. Ann N Y Acad Sci 863:274-290. (Pubitemid 29047782)
38. Kuteeva E, Hökfelt T, Wardi T, Ogren SO (2010) Galanin, galanin receptor subtypes and depression-like behaviour. EXS 102:163-181.
39. Lu X, Sharkey L, Bartfai T (2007) The brain galanin receptors: Targets for novel antidepressant drugs. CNS Neurol Disord Drug Targets 6(3):183-192. (Pubitemid 46916250)
40. Weiss JM, Bonsall RW, Demetrikopoulos MK, Emery MS, West CH (1998) Galanin: A significant role in depression? Ann N Y Acad Sci 863:364-382. (Pubitemid 29047787)
41. Kozlovsky N, Matar MA, Kaplan Z, Zohar J, Cohen H (2009) The role of the galaninergic system in modulating stress-related responses in an animal model of posttraumatic stress disorder. Biol Psychiatry 65(5):383-391.
42. Murck H, et al. (2004) Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29(9):1205-1211. (Pubitemid 38829183)
43. Belfer I, et al. (2007) Alcoholism is associated with GALR3 but not two other galanin receptor genes. Genes Brain Behav 6(5):473-481. (Pubitemid 47024960)
44. Belfer I, et al. (2006) Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 11(3):301-311.
45. Levran O, et al. (2008) Genetic susceptibility to heroin addiction: A candidate gene association study. Genes Brain Behav 7(7):720-729.
46. Jackson KJ, Chen X, Miles MF, Harenza J, Damaj MI (2011) The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence. Neuropsychopharmacology 36(11):2339-2348.
47. Lori A, et al. (2011) The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatment. Neuropsychopharmacology 36(7):1412-1420.
48. Unschuld PG, et al. (2008) Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord 105(1-3):177-184. (Pubitemid 350236362)
49. Unschuld PG, et al. (2010) Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response. Neuropsychopharmacology 35(7):1583-1592.
50. Max MB, et al. (2006) A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. Mol Pain 2:14.
51. Davidson S, et al. (2011) Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: Implications for obesity, depression and alcoholism. Neuropsychopharmacology 36(11):2211-2221.
52. Quinn JP, Warburton A, Myers P, Savage AL, Bubb VJ (2013) Polymorphic variation as a driver of differential neuropeptide gene expression. Neuropeptides 47(6):395-400.
53. McCarroll SA, Hyman SE (2013) Progress in the genetics of polygenic brain disorders: Significant new challenges for neurobiology. Neuron 80(3):578-587.
54. Ripke S, et al.; Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium (2013) A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18(4):497-511.
55. Wray NR, et al. (2012) Genome-wide association study of major depressive disorder: New results, meta-analysis, and lessons learned. Mol Psychiatry 17(1):36-48.
56. Plomin R, Haworth CM, Davis OS (2009) Common disorders are quantitative traits. Nat Rev Genet 10(12):872-878.
57. Belsky J, et al. (2009) Vulnerability genes or plasticity genes? Mol Psychiatry 14(8):746-754.
58. Verzilli CJ, Stallard N, Whittaker JC (2006) Bayesian graphical models for genomewide association studies. Am J Hum Genet 79(1):100-112. (Pubitemid 43927380)
59. Viallefont V, Raftery AE, Richardson S (2001) Variable selection and Bayesian model averaging in case-control studies. Stat Med 20(21):3215-3230. (Pubitemid 33034882)
60. Acid S, De Campos LM, Castellano JG (2005) Learning Bayesian network classifiers: Searching in a space of partially directed acyclic graphs. Mach Learn 59(3):213-253.
61. Ungvári I, et al. (2012) Evaluation of a partial genome screening of two asthma susceptibility regions using bayesian network based Bayesian multilevel analysis of relevance. PLoS ONE 7(3):e33573.
62. Lesch KP, et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527-1531. (Pubitemid 26403928)
63. Karg K, Burmeister M, Shedden K, Sen S (2011) The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 68(5):444-454.
64. Lazary J, et al. (2008) New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biol Psychiatry 64(6):498-504.
65. Caspi A, et al. (2003) Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386-389. (Pubitemid 36877077)
66. Hamon M, Blier P (2013) Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry 45:54-63.
67. Borroto-Escuela DO, et al. (2010) Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochem Biophys Res Commun 393(4):767-772.
68. Pieribone VA, et al. (1995) Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neuroscience 64(4):861-874.
69. Vila-Porcile E, et al. (2009) Dendritic synthesis and release of the neuropeptide galanin: Morphological evidence from studies on rat locus coeruleus neurons. J Comp Neurol 516(3):199-212.
70. Coumis U, Davies CH (2002) The effects of galanin on long-term synaptic plasticity in the CA1 area of rodent hippocampus. Neuroscience 112(1):173-182. (Pubitemid 34603508)
71. Swanson CJ, et al. (2005) Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci USA 102(48):17489-17494. (Pubitemid 41740893)
72. Xu ZQ, Zhang X, Pieribone VA, Grillner S, Hökfelt T (1998) Galanin-5-hydroxytryptamine interactions: Electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 87(1):79-94. (Pubitemid 28351170)
73. Frodl T, et al. (2002) Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 159(7):1112-1118. (Pubitemid 34743250)
74. Hajszan T, et al. (2009) Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol Psychiatry 65(5):392-400.
75. Sheline YI, Sanghavi M, Mintun MA, Gado MH (1999) Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19(12):5034-5043. (Pubitemid 29270138)
76. Arnone D, et al. (2013) State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry 18(12):1265-1272.
77. Castrén E (2004) Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4(1):58-64.
78. Hajszan T, MacLusky NJ (2006) Neurologic links between epilepsy and depression in women: Is hippocampal neuroplasticity the key? Neurology 66(6, Suppl 3):S13-S22. (Pubitemid 43739804)
79. Nestler EJ, et al. (2002) Neurobiology of depression. Neuron 34(1):13-25. (Pubitemid 34270695)
80. Elliott-Hunt CR, et al. (2004) Galanin acts as a neuroprotective factor to the hippocampus. Proc Natl Acad Sci USA 101(14):5105-5110. (Pubitemid 38469210)
81. Mazarati AM, et al. (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 18(23): 10070-10077. (Pubitemid 28543781)
82. Pirondi S, et al. (2005) The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells. J Neurochem 95(3):821-833. (Pubitemid 41567173)
83. Elliott-Hunt CR, Pope RJ, Vanderplank P, Wynick D (2007) Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage. J Neurochem 100(3):780-789. (Pubitemid 46095627)
84. Gage FH (2000) Mammalian neural stem cells. Science 287(5457):1433-1438.
85. Ming GL, Song H (2005) Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28:223-250.
86. Duman RS, Malberg J, Thome J (1999) Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46(9):1181-1191. (Pubitemid 30114436)
87. Jacobs BL, van Praag H, Gage FH (2000) Adult brain neurogenesis and psychiatry: A novel theory of depression. Mol Psychiatry 5(3):262-269. (Pubitemid 30438401)
88. Malberg JE, Schechter LE (2005) Increasing hippocampal neurogenesis: A novel mechanism for antidepressant drugs. Curr Pharm Des 11(2):145-155. (Pubitemid 40089838)
89. Abbosh C, Lawkowski A, Zaben M, Gray W (2011) GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursors. J Neurochem 117(3):425-436.
90. Hobson SA, et al. (2008) Galanin acts as a trophic factor to the central and peripheral nervous systems. Cell Mol Life Sci 65(12):1806-1812.
91. Mansouri S, et al. (2013) GalR3 activation promotes adult neural stem cell survival in response to a diabetic milieu. J Neurochem 127(2):209-220.
92. Spalding KL, et al. (2013) Dynamics of hippocampal neurogenesis in adult humans. Cell 153(6):1219-1227.
93. Eriksson PS, et al. (1998) Neurogenesis in the adult human hippocampus. Nat Med 4(11):1313-1317. (Pubitemid 28512114)
94. Anisimov SV, et al. (2002) SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells. Genomics 79(2):169-176.
95. Assou S, et al. (2007) A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25(4):961-973. (Pubitemid 46572593)
96. Lundström L, Elmquist A, Bartfai T, Langel U (2005) Galanin and its receptors in neurological disorders. Neuromolecular Med 7(1-2):157-180. (Pubitemid 41278195)
97. Badie-Mahdavi H, Lu X, Behrens MM, Bartfai T (2005) Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3′,5′-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: Studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice. Neuroscience 133(2):591-604. (Pubitemid 40726225)
98. Kinney JW, et al. (2009) Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylation. Neurobiol Learn Mem 92(3):429-438.
99. Hawes JJ, et al. (2008) Galanin protects against behavioral and neurochemical correlates of opiate reward. Neuropsychopharmacology 33(8):1864-1873. (Pubitemid 351832595)
100. Castrén E, Rantamäki T (2010) Role of brain-derived neurotrophic factor in the aetiology of depression: Implications for pharmacological treatment. CNS Drugs 24(1):1-7.
101. Martinowich K, Manji H, Lu B (2007) New insights into BDNF function in depression and anxiety. Nat Neurosci 10(9):1089-1093. (Pubitemid 47339961)
102. Juhasz G, et al. (2011) The CREB1-BDNF-NTRK2 pathway in depression: Multiple gene-cognition-environment interactions. Biol Psychiatry 69(8):762-771.
103. Juhasz G, et al. (2009) CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 34(8):2019-2027.
104. Heim C, Nemeroff CB (2001) The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies. Biol Psychiatry 49(12):1023-1039. (Pubitemid 32595461)
105. Brugha T, Bebbington P, Tennant C, Hurry J (1985) The list of threatening experiences: A subset of 12 life event categories with considerable long-term contextual threat. Psychol Med 15(1):189-194. (Pubitemid 15133493)
106. Derogatis LR (1993) BSI: Brief Symptom Inventory: Administration, Scoring, and Procedures Manual (National Computer Systems Pearson, Minneapolis, MN).
107. Bernstein DP, et al. (1994) Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry 151(8):1132-1136. (Pubitemid 24240954)
108. Freeman B, et al. (2003) DNA from buccal swabs recruited by mail: Evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 33(1):67-72. (Pubitemid 36176783)